{{Rsnum
|rsid=198388
|Gene=NPPB
|Chromosome=1
|position=11857283
|Orientation=plus
|GMAF=0.382
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NPPB
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 27.4 | 54.9 | 17.7
| HCB | 66.4 | 30.7 | 2.9
| JPT | 70.8 | 27.4 | 1.8
| YRI | 6.8 | 47.3 | 45.9
| ASW | 17.5 | 49.1 | 33.3
| CHB | 66.4 | 30.7 | 2.9
| CHD | 70.6 | 24.8 | 4.6
| GIH | 26.7 | 51.5 | 21.8
| LWK | 10.0 | 50.9 | 39.1
| MEX | 55.2 | 39.7 | 5.2
| MKK | 7.1 | 45.5 | 47.4
| TSI | 26.5 | 52.9 | 20.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=19326473
|Title=Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting.
|OA=1
}}

{{PMID Auto
|PMID=20346360
|Title=Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease.
|OA=1
}}

{{PMID Auto
|PMID=21273288
|Title=Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster.
|OA=1
}}

{{PMID Auto
|PMID=21276798
|Title=Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}